Sep 1, 2026 · 1h 46m
Pentagon memo urges routine testosterone screening for warfighters
STOP Treating Low Testosterone As Depression: The 160 Reading Navy Doctor Refused | Tim Parlatore
The discussion connects military stress, sleep loss, brain injury and untreated hormone deficiency to readiness, veteran health and suicide prevention.
- 1Routine testosterone testing could identify symptomatic deficiency before it undermines service members’ health, performance and deployability.
- 2The proposed approach separates medically supervised treatment from illicit anabolic use and preserves individualized medical choice.
- 3Parlatori links military healthcare reform to broader concerns about prosecutorial misconduct, secondary trauma and preventable veteran suicide.
Don't miss
Parlatori recounts how a senior Navy officer’s testosterone level of 160, followed by treatment, weight loss and improved readiness, sharpened the case for routine screening.
The brief
Tim Parlatori and Dr. Gabrielle Lyon frame low testosterone as a possible consequence of combat stress, sleep deprivation, traumatic brain injury and chronic strain—not simply a performance-enhancement issue.
Parlatori’s Pentagon memo calls for testosterone testing during annual physicals, followed by specialist evaluation and symptom-based treatment rather than automatic prescriptions.
The episode’s clearest case is a senior Navy officer initially denied testing who recorded a testosterone level of 160, then improved his weight and physical readiness after treatment.
The conversation distinguishes supervised care from anabolic steroid abuse while weighing fertility, treatment alternatives, medical autonomy and the risks of self-medication.
Parlatori then connects military health to his criminal-defense work, describing alleged prosecutorial misconduct, lawyers’ secondary trauma and the institutional failures he believes can worsen veteran suicide.